Apotex Pty Ltd — APO-Cabergoline 500mcg tablets
What are the defects?
Apotex Pty Ltd is recalling one batch of the APO-Cabergoline 500mcg tablets (batch MK0903, expiry date February 2017) due to a packaging issue, where the desiccant may not protect the product from moisture throughout its shelf life.
What are the hazards?
Failure to protect the product from moisture could lead to the product degrading over time in moist conditions. Product degradation may affect the efficacy of the product.
What should consumers do?
Therapeutic Goods Administration is the responsible regulator for this recall.